Christopher Martell - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Martell since 12/14/2024

Holdings reported by Christopher Martell for Candel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 284K $1.36M $4.81 Jun 25, 2025 By GTAM1 2012 ADV LLC
Common Stock 152K $731K $4.81 Jun 25, 2025 By GTAM1 2012 LLC
Common Stock 111K $520K $4.67 Jun 25, 2025 By Spouse
Stock Option (Right to Buy) 14.2K Jun 17, 2025 Direct Common Stock

Transactions reported by Christopher Martell for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.